Last week, members of Congress from both parties introduced a series of bills to curtail the dominance of the major technology firms. We asked Prof. Fiona Scott Morton if the proposed legislation would help level the playing field.
Yale SOM’s Fiona Scott Morton and her co-authors argue that smarter and more robust antitrust enforcement can help, by making room for new social media platforms that promote themselves as healthier alternatives.
On October 20, the U.S. Justice Department filed suit against Google, accusing the company of illegally using its market power to maintain dominance of online search and advertising. We asked Yale SOM antitrust expert Fiona Scott Morton to explain why antitrust violations are bad for consumers and how the government can respond.
In a new paper, Yale SOM’s Fiona Scott Morton writes that the company took control of the social media industry by misleading consumers and buying up rivals.
State and federal authorities are reportedly preparing to bring antitrust charges against Google. We talked to Yale SOM’s Fiona Scott Morton about the company's dominant role in online advertising and how it limits competition.
Companies often purchase competitors, not to acquire their ideas and products, but to shut them down. A recent report raised questions about whether such an acquisition may be partially responsible for a shortage of ventilators in the United States.
What will the sudden economic shock mean for competition and antitrust policy? We asked Yale SOM’s Fiona Scott Morton, an economist who served in the Antitrust Division of the U.S. Department of Justice, for her perspective.
More and more of our economic and social lives are being conducted through digital channels. Economist Fiona Scott Morton talks about how effective antitrust regulation and enforcement can ensure that consumers benefit from the next killer app.
Instead, argues Yale SOM’s Fiona Scott Morton, the government should exercise its regulatory powers to promote competition.
A recent lawsuit alleged that a billionaire investor bought the rights to a new drug just to eliminate a potential competitor. We asked Yale SOM's Florian Ederer to explain why a "catch-and-kill" merger can be damaging and what to do about the phenomenon.
Prof. Scott Morton called a private healthcare system without competitive pressure “the worst of both worlds” in terms of costs.